GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Jointown Pharmaceutical Group Co Ltd (SHSE:600998) » Definitions » Research & Development

Jointown Pharmaceutical Group Co (SHSE:600998) Research & Development : ¥202 Mil (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Jointown Pharmaceutical Group Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Jointown Pharmaceutical Group Co's Research & Development for the three months ended in Mar. 2024 was ¥44 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥202 Mil.


Jointown Pharmaceutical Group Co Research & Development Historical Data

The historical data trend for Jointown Pharmaceutical Group Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jointown Pharmaceutical Group Co Research & Development Chart

Jointown Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 74.13 126.63 194.94 178.39 196.61

Jointown Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.92 49.02 43.48 65.19 44.25

Jointown Pharmaceutical Group Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥202 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jointown Pharmaceutical Group Co  (SHSE:600998) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Jointown Pharmaceutical Group Co Research & Development Related Terms

Thank you for viewing the detailed overview of Jointown Pharmaceutical Group Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Jointown Pharmaceutical Group Co (SHSE:600998) Business Description

Traded in Other Exchanges
N/A
Address
No 8 Longyang Road, Hanyang District, Wuhan, CHN, 430051
Jointown Pharmaceutical Group Co Ltd is engaged in the business of wholesaling drugs and medical devices. The company offers logistics and other value-added services and primarily serves medical institutions, wholesale enterprises, and retail pharmacies.
Executives
Liu Yi Chang Director
Ai Hua Director
Wang Qi Bing senior management
Gong Yi Hua Directors, senior managers
Lin Xin Yang Directors, senior managers
Yang Ju Mei senior management
Chen Qi Ming Directors, senior managers
Chen Li Supervisors
Guo Lei senior management
Liu Su Fang senior management
Xu Ming Zhen senior management
Chen Song Bai senior management
Huang Li Hua senior management
Wang Jia Ming senior management
Chen Bo senior management

Jointown Pharmaceutical Group Co (SHSE:600998) Headlines

No Headlines